Printable: U.S. FDA Approves Tec-Dara for the Treatment of Relapsed/Refractory Multiple Myeloma

U.S. FDA Approves Tec-Dara for the Treatment of Relapsed/Refractory Multiple Myeloma (https://www.myeloma.org/news-events/multiple-myeloma-news/fda-approves-tec-dara-for-treatment-of-rrmm)

Source URL: https://www.myeloma.org/news-events/multiple-myeloma-news/fda-approves-tec-dara-for-treatment-of-rrmm